Coronavirus Regulatory and Legal-DEA

Coronavirus Regulatory and Legal-DEA

Home / Coronavirus Regulatory and Legal-DEA

LEGAL/REGULATORY—DEA 
March 22, 2020


Click here to download a PDF version of this page

Legal Helpline is available at (720) 858-6030—Monday–Friday 8am to 5pm
We are receiving a high call volume and want to assure you that if you leave a message, we will respond in a timely manner. If you have been working with a specific staff member you should continue to contact them on their direct line or via email.

DEA Exception on Ryan Haight to Combat Coronavirus
The DEA has invoked an exception to the in-person examination requirement under the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. 829). While the COVID-19 public health emergency remains in effect, practitioners may issue prescriptions for controlled substances (schedules II-IV) to patients for whom they have not conducted an in-person medical evaluation, provided all the following conditions are met:
• The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice.
• The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system.
• The practitioner is acting in accordance with applicable federal and state law.

In addition, for the prescription to be valid, the practitioner must comply with any applicable state laws.  

For more information, please go to https://www.deadiversion.usdoj.gov/coronavirus.html